More bat viruses are coming so buy these biotechs, Jefferies says

In this picture taken on April 29, 2020, an engineer works at the Quality Control Laboratory on an experimental vaccine for the COVID-19 coronavirus at the Sinovac Biotech facilities in Beijing.
Nicolas Asfouri | AFP | Getty Images

(This story is for CNBC Pro subscribers only.)

As the hunt for a vaccine against the coronavirus continues around the world, health-care analysts at Jefferies warned more diseases from wild habitats are inevitable.

The trend would be dangerous for the economy and the financial markets, which suffered the fastest bear market in March during the current pandemic, but it could leave one bright spot for investors to bet on — biotech companies.